Extendicare (TSE:EXE – Get Free Report) had its price target hoisted by stock analysts at CIBC from C$18.00 to C$22.00 in a research report issued to clients and investors on Thursday,BayStreet.CA reports. CIBC’s price target indicates a potential upside of 15.73% from the stock’s previous close.
EXE has been the topic of a number of other reports. TD Securities lifted their price objective on Extendicare from C$15.00 to C$19.00 in a research report on Thursday. Cibc World Mkts raised Extendicare to a “strong-buy” rating in a report on Monday, September 22nd. National Bankshares lifted their price objective on shares of Extendicare from C$16.10 to C$17.50 and gave the company an “outperform” rating in a research report on Wednesday, October 8th. Finally, National Bank Financial upgraded shares of Extendicare to a “strong-buy” rating in a research report on Wednesday, July 16th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of C$16.80.
View Our Latest Analysis on Extendicare
Extendicare Stock Performance
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading
- Five stocks we like better than Extendicare
- Best Energy Stocks – Energy Stocks to Buy Now
- AMD to $300 Looks Easy—Here’s Why $500 Could Be Next
- What Investors Need to Know About Upcoming IPOs
- $5B+ in Buybacks: What DraftKings, AppLovin, and Altria Are Telling You
- EV Stocks and How to Profit from Them
- 4 High-Yield Real Estate Stocks to Buy as Investors Get Defensive
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
